<DOC>
	<DOCNO>NCT00227409</DOCNO>
	<brief_summary>Previous study show repeat lead chelation therapy significant reduce progressive renal insufficiency patient chronic renal disease high-normal body lead burden placebo-controlled , randomize , 2-year clinical trial , even factor influence progression , blood pressure , presence absence hyperlipidemia , urinary protein excretion well controlled.Since relative small sample size short duration follow-up note previous study , whether repeat lead chelation therapy could long-term retard progression renal insufficiency remain unknown . Hence , conduct 51-month placebo-controlled clinical trial ass long-term effect repeat chelation progressive renal insufficiency patient high-normal body lead burden .</brief_summary>
	<brief_title>Long-Term Lead Chelation Therapy Progressive Renal Insufficiency</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Urologic Diseases</mesh_term>
	<mesh_term>Pentetic Acid</mesh_term>
	<mesh_term>Edetic Acid</mesh_term>
	<criteria>Patients 18 80 year age chronic renal insufficiency eligible serum creatinine concentration 1.5 mg per deciliter ( 132.6 μmol per liter ) 3.9 mg per deciliter ( 344.8 μmol per liter ) , decrease glomerular filtration rate le 5 ml per minute period least six month Blood pressure le 140/90 mm Hg A cholesterol level 240 mg per deciliter Daily protein intake 1 g per kilogram body weight No known history exposure lead heavy metal , highnormal body lead burden ( 60 600 μg , measure EDTA mobilization test 72hour urine collection ) . Patients renal insufficiency potentially reversible cause , malignant hypertension , urinary tract infection , hypercalcemia , druginduced nephrotoxic effect Systemic disease , connectivetissue disease diabetes mellitus Use drug might alter course renal disease , nonsteroidal antiinflammatory agent , steroid , immunosuppressive drug Rapidly progressive glomerulonephritis high level 24hour urinary protein excretion ( 8 g per day ) Previous mark exposure lead metal ( lead poison occupational exposure ) Drug allergy Absence inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Repeated chelation therapy</keyword>
	<keyword>Progressive renal insufficiency</keyword>
	<keyword>Body lead burden</keyword>
	<keyword>Long-term outcome</keyword>
	<keyword>Glomerular filtration rate</keyword>
</DOC>